OWP Pharmaceuticals, Inc.
7 drugs in NADAC|7 Generic,0 Brand
OWP Pharmaceuticals, Inc. lists 7 NDCs in the CMS NADAC file (7 generic, 0 brand), at an average NADAC of $4.16 per unit, with a week-over-week move of -1.0% across products that moved. The firm's full portfolio, pricing trend are listed below.
Total Drugs
7
7G / 0B
Avg Price / Unit
$4.1558
$0.03 – $14.39
Avg 7d Change
-1.00%
Across 5 drugs with changes
7d Activity
of 7 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Keep following this manufacturer
These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.
Lead market
LAMOTRIGINE market
See the molecule this manufacturer shows up in most often and compare it against competing suppliers.
Lead class
Anti-epileptic Agent therapeutic class
Review the broader class where OWP Pharmaceuticals, Inc. has the strongest current portfolio footprint.
Trend hub
Portfolio trend view
Jump to the trend hub to compare this manufacturer against the rest of the market on weekly price movement.
Guide
NADAC pricing primer
Use the explainer for context on the benchmark this manufacturer is being compared against.
Frequently Asked Questions
How many drugs does OWP Pharmaceuticals, Inc. make?
OWP Pharmaceuticals, Inc. lists 7 NDCs in the CMS NADAC file — 7 generic and 0 brand products.
What is the average price of OWP Pharmaceuticals, Inc. drugs?
The average NADAC across OWP Pharmaceuticals, Inc.'s portfolio is $4.1558 per unit, ranging from $0.0268 to $14.3949.
What types of drugs does OWP Pharmaceuticals, Inc. make?
OWP Pharmaceuticals, Inc. makes drugs across 2 FDA pharmacologic classes. The most common by NDC count are Anti-epileptic Agent (4), Mood Stabilizer (4).
Has OWP Pharmaceuticals, Inc. had any drug recalls?
No FDA enforcement recalls are matched to OWP Pharmaceuticals, Inc. in the openFDA feed.
How has OWP Pharmaceuticals, Inc.'s pricing changed recently?
Over the past 7 days, 0 OWP Pharmaceuticals, Inc. products rose and 5 fell, with a portfolio-wide average change of -1.0%.
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
SUBVENITE TAB START KT(ORANGE) LAMOTRIGINE | $14.3949 per EA | — |
LAMOTRIGINE TAB START KT-ORANG LAMOTRIGINE | $14.3949 per EA | — |
SUBVENITE 200 MG TABLET LAMOTRIGINE | $0.0825 per EA | -1.80% |
ROWEEPRA 500 MG TABLET Levetiracetam | $0.0736 per EA | -0.39% |
SUBVENITE 150 MG TABLET LAMOTRIGINE | $0.0695 per EA | -1.71% |
SUBVENITE 100 MG TABLET LAMOTRIGINE | $0.0487 per EA | -0.02% |
SUBVENITE 25 MG TABLET LAMOTRIGINE | $0.0268 per EA | -1.07% |